SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'LAT'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CLA_A_CLMA221_0 (TYPE IIICHLORAMPHENICOLACETYLTRANSFERASE) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 5 / 10 | THR A 48PHE A 65ALA A 64ASN A 51VAL A 29 | NoneNoneLAT A 201 ( 4.2A)NoneNone | 1.33A | 1claA-3wg1A:undetectable | 1claA-3wg1A:22.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DY4_A_SNPA437_1 (EXOGLUCANASE 1) |
1z3v | CELLULASE (Phanerochaetechrysosporium) | 10 / 12 | ALA A 140TYR A 142ASP A 170SER A 171GLN A 172GLU A 207ASP A 209GLU A 212ARG A 240ASP A 366 | NoneNoneNoneNoneLAT A 500 (-3.3A)NoneNoneLAT A 500 ( 4.5A)LAT A 500 (-3.1A)None | 0.54A | 1dy4A-1z3vA:62.2 | 1dy4A-1z3vA:55.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DY4_A_SNPA437_1 (EXOGLUCANASE 1) |
1z3v | CELLULASE (Phanerochaetechrysosporium) | 10 / 12 | ALA A 140TYR A 142TYR A 168ASP A 170SER A 171GLN A 172GLU A 207ASP A 209GLU A 212ASP A 366 | NoneNoneNoneNoneNoneLAT A 500 (-3.3A)NoneNoneLAT A 500 ( 4.5A)None | 0.24A | 1dy4A-1z3vA:62.2 | 1dy4A-1z3vA:55.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DY4_A_SNPA437_2 (EXOGLUCANASE 1) |
1z3v | CELLULASE (Phanerochaetechrysosporium) | 4 / 5 | HIS A 223TRP A 364ALA A 369TRP A 373 | LAT A 500 ( 4.9A)NoneLAT A 500 ( 4.3A)LAT A 500 (-3.7A) | 0.29A | 1dy4A-1z3vA:62.2 | 1dy4A-1z3vA:55.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HO5_A_ADNA1604_1 (5'-NUCLEOTIDASE) |
4izx | RICIN B-LIKE LECTIN (Macrolepiotaprocera) | 5 / 11 | ILE A 31ASN A 28GLY A 119GLY A 33ASP A 22 | NoneNoneNoneNoneLAT A 201 (-2.8A) | 1.23A | 1ho5A-4izxA:undetectable | 1ho5A-4izxA:13.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I1E_A_DM2A3001_1 (BOTULINUM NEUROTOXINTYPE B) |
1dll | TETANUS TOXIN (Clostridiumtetani) | 5 / 9 | GLY A1269HIS A1271SER A1287TRP A1289TYR A1290 | NoneLAT A2000 ( 4.9A)GOL A3000 ( 2.6A)GOL A3000 ( 3.3A)GOL A3000 ( 4.0A) | 0.44A | 1i1eA-1dllA:0.0 | 1i1eA-1dllA:15.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_A_MTLA870_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
4ym3 | GALECTIN-4 (Homosapiens) | 4 / 8 | SER A 220ASN A 238GLN A 313PHE A 221 | NoneLAT A 401 (-4.0A)NoneNone | 1.35A | 1rs6A-4ym3A:undetectable | 1rs6A-4ym3A:15.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS7_B_MTLB871_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
4ym3 | GALECTIN-4 (Homosapiens) | 4 / 8 | SER A 220ASN A 238GLN A 313PHE A 221 | NoneLAT A 401 (-4.0A)NoneNone | 1.34A | 1rs7B-4ym3A:undetectable | 1rs7B-4ym3A:15.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3478_1 (NEURAMINIDASE) |
4izx | RICIN B-LIKE LECTIN (Macrolepiotaprocera) | 4 / 8 | SER A 60SER A 62SER A 57GLN A 42 | NoneNoneNoneLAT A 201 ( 4.4A) | 0.82A | 2cmlC-4izxA:undetectable | 2cmlC-4izxA:16.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIL_W_CHDW1060_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 1) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 8 | ILE A 118PHE A 96ARG A 66LEU A 50 | NoneNoneLAT A 201 (-3.0A)None | 0.88A | 2eilN-3wg1A:undetectable2eilW-3wg1A:undetectable | 2eilN-3wg1A:15.152eilW-3wg1A:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNH_B_9CRB502_1 (CYTOCHROME P450 2C8) |
4i4s | BEL BETA-TREFOIL (Boletusedulis) | 5 / 10 | ILE A 24LEU A 71ASN A 93ASN A 67ILE A 84 | NoneNoneLAT A 201 (-3.1A)NoneLAT A 201 (-3.9A) | 1.22A | 2nnhB-4i4sA:undetectable | 2nnhB-4i4sA:16.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ABL_W_CHDW1060_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 1) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 8 | ILE A 118PHE A 96ARG A 66LEU A 50 | NoneNoneLAT A 201 (-3.0A)None | 0.92A | 3ablN-3wg1A:undetectable3ablW-3wg1A:undetectable | 3ablN-3wg1A:15.153ablW-3wg1A:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG3_W_CHDW1059_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 1) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 8 | ILE A 118PHE A 96ARG A 66LEU A 50 | NoneNoneLAT A 201 (-3.0A)None | 0.84A | 3ag3N-3wg1A:undetectable3ag3W-3wg1A:undetectable | 3ag3N-3wg1A:15.153ag3W-3wg1A:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_A_SVRA508_1 (PHOSPHOLIPASE A2) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 4 / 5 | VAL C 172PHE C 149ARG C 186ARG C 169 | NoneNoneLAT C 301 (-4.0A)None | 1.38A | 3bjwE-6fofC:undetectable | 3bjwE-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DH0_A_SAMA220_0 (SAM DEPENDENTMETHYLTRANSFERASE) |
1gzc | ERYTHRINACRISTA-GALLI LECTIN (Erythrinacrista-galli) | 5 / 12 | GLY A 90ALA A 88PHE A 131THR A 130LEU A 160 | NoneLAT A1559 ( 3.8A)LAT A1559 ( 3.7A)NoneNone | 0.72A | 3dh0A-1gzcA:undetectable | 3dh0A-1gzcA:19.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 6 / 6 | HIS A 44ASN A 46ARG A 48ASN A 61TRP A 68GLU A 71 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A) | 0.32A | 3galA-3m2mA:20.1 | 3galA-3m2mA:30.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 5 / 6 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A) | 0.37A | 3galA-3wg1A:16.1 | 3galA-3wg1A:23.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
4bmb | GALECTIN-8 (Homosapiens) | 6 / 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.25A | 3galA-4bmbA:23.3 | 3galA-4bmbA:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
4ym3 | GALECTIN-4 (Homosapiens) | 6 / 6 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.27A | 3galA-4ym3A:22.8 | 3galA-4ym3A:36.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
5dux | GALECTIN-4 (Homosapiens) | 6 / 6 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.25A | 3galA-5duxB:24.8 | 3galA-5duxB:36.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
5gzg | GALECTIN-8 (Homosapiens) | 6 / 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.29A | 3galA-5gzgA:23.2 | 3galA-5gzgA:29.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_A_1GNA998_1 (GALECTIN-7) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 6 / 6 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A) | 0.26A | 3galA-6fofC:22.3 | 3galA-6fofC:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 6 / 6 | HIS A 44ASN A 46ARG A 48ASN A 61TRP A 68GLU A 71 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A) | 0.34A | 3galB-3m2mA:19.6 | 3galB-3m2mA:30.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 5 / 6 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A) | 0.48A | 3galB-3wg1A:15.6 | 3galB-3wg1A:23.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
4bmb | GALECTIN-8 (Homosapiens) | 4 / 6 | HIS A 65ASN A 67ARG A 45TRP A 86 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.9A)LAT A1155 (-3.6A) | 1.22A | 3galB-4bmbA:23.0 | 3galB-4bmbA:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
4bmb | GALECTIN-8 (Homosapiens) | 6 / 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.35A | 3galB-4bmbA:23.0 | 3galB-4bmbA:32.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
4ym3 | GALECTIN-4 (Homosapiens) | 6 / 6 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.30A | 3galB-4ym3A:22.6 | 3galB-4ym3A:36.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
5dux | GALECTIN-4 (Homosapiens) | 6 / 6 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.34A | 3galB-5duxB:24.5 | 3galB-5duxB:36.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
5gzg | GALECTIN-8 (Homosapiens) | 5 / 6 | HIS A 65ASN A 67ARG A 45ASN A 79TRP A 86 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.8A)LAT A 201 (-3.6A)LAT A 201 (-3.7A) | 1.43A | 3galB-5gzgA:22.9 | 3galB-5gzgA:29.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
5gzg | GALECTIN-8 (Homosapiens) | 6 / 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.37A | 3galB-5gzgA:22.9 | 3galB-5gzgA:29.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GAL_B_1GNB999_1 (GALECTIN-7) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 6 / 6 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A) | 0.42A | 3galB-6fofC:22.3 | 3galB-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JAY_A_SAMA1102_1 (STRUCTURAL PROTEINVP3) |
5dux | GALECTIN-4 (Homosapiens) | 3 / 3 | ARG B 67ASP B 141ASP B 69 | LAT B 201 (-2.6A)NoneNone | 0.73A | 3jayA-5duxB:undetectable | 3jayA-5duxB:9.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JB2_A_SAMA1102_1 (STRUCTURAL PROTEINVP3) |
5dux | GALECTIN-4 (Homosapiens) | 3 / 3 | ARG B 67ASP B 141ASP B 69 | LAT B 201 (-2.6A)NoneNone | 0.74A | 3jb2A-5duxB:undetectable | 3jb2A-5duxB:9.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JB3_A_SAMA1102_1 (STRUCTURAL PROTEINVP3) |
5dux | GALECTIN-4 (Homosapiens) | 3 / 3 | ARG B 67ASP B 141ASP B 69 | LAT B 201 (-2.6A)NoneNone | 0.67A | 3jb3A-5duxB:undetectable | 3jb3A-5duxB:9.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KL3_A_DHIA403_0 (GLUCURONOXYLANASEXYNC) |
1gzc | ERYTHRINACRISTA-GALLI LECTIN (Erythrinacrista-galli) | 4 / 4 | GLY A 105TYR A 106GLY A 217ASP A 46 | NoneNoneLAT A1559 (-3.1A)None | 1.04A | 3kl3A-1gzcA:undetectable | 3kl3A-1gzcA:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_B_PXLB400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
4bmb | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A1155 (-3.9A) NA A1156 (-3.3A)NoneGOL A1157 (-3.6A) | 1.48A | 3mbhB-4bmbA:undetectable | 3mbhB-4bmbA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_B_PXLB400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
5gzg | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A 201 (-3.9A) NA A 202 (-3.3A)NoneNone | 1.47A | 3mbhB-5gzgA:undetectable | 3mbhB-5gzgA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_C_PXLC400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
4bmb | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A1155 (-3.9A) NA A1156 (-3.3A)NoneGOL A1157 (-3.6A) | 1.46A | 3mbhC-4bmbA:undetectable | 3mbhC-4bmbA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_C_PXLC400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
5gzg | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A 201 (-3.9A) NA A 202 (-3.3A)NoneNone | 1.45A | 3mbhC-5gzgA:undetectable | 3mbhC-5gzgA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_D_PXLD400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
4bmb | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A1155 (-3.9A) NA A1156 (-3.3A)NoneGOL A1157 (-3.6A) | 1.49A | 3mbhD-4bmbA:undetectable | 3mbhD-4bmbA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_D_PXLD400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
5gzg | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A 201 (-3.9A) NA A 202 (-3.3A)NoneNone | 1.48A | 3mbhD-5gzgA:undetectable | 3mbhD-5gzgA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_E_PXLE400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
4bmb | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A1155 (-3.9A) NA A1156 (-3.3A)NoneGOL A1157 (-3.6A) | 1.49A | 3mbhE-4bmbA:undetectable | 3mbhE-4bmbA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_E_PXLE400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
5gzg | GALECTIN-8 (Homosapiens) | 5 / 12 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A 201 (-3.9A) NA A 202 (-3.3A)NoneNone | 1.47A | 3mbhE-5gzgA:undetectable | 3mbhE-5gzgA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBH_F_PXLF400_1 (PUTATIVEPHOSPHOMETHYLPYRIMIDINE KINASE) |
4bmb | GALECTIN-8 (Homosapiens) | 5 / 11 | VAL A 62HIS A 65GLN A 47VAL A 20TYR A 141 | NoneLAT A1155 (-3.9A) NA A1156 (-3.3A)NoneGOL A1157 (-3.6A) | 1.48A | 3mbhF-4bmbA:undetectable | 3mbhF-4bmbA:18.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_K_BO2K1402_1 (PROTEASOME COMPONENTPRE2PROTEASOME COMPONENTC5) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 5 / 11 | ALA A 49THR A 48ALA A 64ALA A 15GLY A 14 | NoneNoneLAT A 201 ( 4.2A)NoneNone | 0.86A | 3mg0K-3wg1A:undetectable3mg0L-3wg1A:undetectable | 3mg0K-3wg1A:19.743mg0L-3wg1A:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_Y_BO2Y1403_1 (PROTEASOME COMPONENTPRE2PROTEASOME COMPONENTC5) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 5 / 12 | ALA A 49THR A 48ALA A 64ALA A 15GLY A 14 | NoneNoneLAT A 201 ( 4.2A)NoneNone | 0.88A | 3mg0Y-3wg1A:undetectable3mg0Z-3wg1A:undetectable | 3mg0Y-3wg1A:19.743mg0Z-3wg1A:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NU9_A_478A401_1 (PROTEASE) |
4a3x | EPA1P ([Candida]glabrata) | 4 / 8 | ALA A 163ASP A 165ILE A 109VAL A 169 | NoneLAT A1269 ( 2.5A)NoneNone | 0.72A | 3nu9A-4a3xA:undetectable | 3nu9A-4a3xA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_C_W9TC1005_1 (HEMOLYTIC LECTINCEL-III) |
4izx | RICIN B-LIKE LECTIN (Macrolepiotaprocera) | 3 / 3 | ASP A 22GLY A 25TYR A 34 | LAT A 201 (-2.8A)LAT A 201 (-3.5A)LAT A 201 ( 3.5A) | 0.54A | 3w9tC-4izxA:16.4 | 3w9tC-4izxA:17.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W9T_G_W9TG503_1 (HEMOLYTIC LECTINCEL-III) |
4izx | RICIN B-LIKE LECTIN (Macrolepiotaprocera) | 3 / 3 | ASP A 22GLY A 25TYR A 34 | LAT A 201 (-2.8A)LAT A 201 (-3.5A)LAT A 201 ( 3.5A) | 0.53A | 3w9tG-4izxA:16.5 | 3w9tG-4izxA:17.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IPM_A_ACTA503_0 (GH7 FAMILY PROTEIN) |
1z3v | CELLULASE (Phanerochaetechrysosporium) | 9 / 9 | ASN A 138ALA A 140TYR A 142TYR A 168ASP A 170GLU A 207ASP A 209GLU A 212TRP A 364 | NoneNoneNoneNoneNoneNoneNoneLAT A 500 ( 4.5A)None | 0.47A | 4ipmA-1z3vA:62.5 | 4ipmA-1z3vA:55.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCN_B_MTLB806_0 (NITRIC OXIDESYNTHASE, BRAIN) |
4ym3 | GALECTIN-4 (Homosapiens) | 4 / 7 | SER A 220ASN A 238GLN A 313PHE A 221 | NoneLAT A 401 (-4.0A)NoneNone | 1.44A | 4kcnB-4ym3A:undetectable | 4kcnB-4ym3A:17.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QTU_B_SAMB301_1 (PUTATIVEMETHYLTRANSFERASEBUD23) |
1z3v | CELLULASE (Phanerochaetechrysosporium) | 4 / 5 | TYR A 168SER A 362ASP A 209ASP A 251 | NoneNoneNoneLAT A 500 ( 3.8A) | 1.23A | 4qtuB-1z3vA:undetectable | 4qtuB-1z3vA:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IY5_W_CHDW101_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 7 | ILE A 118PHE A 96ARG A 66LEU A 50 | NoneNoneLAT A 201 (-3.0A)None | 0.92A | 5iy5N-3wg1A:undetectable5iy5W-3wg1A:undetectable | 5iy5N-3wg1A:15.155iy5W-3wg1A:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1431_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 4 / 5 | HIS A 52ASP A 125GLY A 124ASN A 46 | LAT A 999 (-3.9A)NoneNoneLAT A 999 (-4.1A) | 1.41A | 5x7pB-3m2mA:undetectable | 5x7pB-3m2mA:6.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 7 / 7 | HIS A 44ASN A 46ARG A 48ASN A 61TRP A 68GLU A 71ARG A 73 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A)LAT A 999 ( 4.7A) | 0.47A | 6b8kA-3m2mA:19.9 | 6b8kA-3m2mA:36.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 6 / 7 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.47A | 6b8kA-3wg1A:15.8 | 6b8kA-3wg1A:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
4bmb | GALECTIN-8 (Homosapiens) | 6 / 7 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.17A | 6b8kA-4bmbA:23.2 | 6b8kA-4bmbA:28.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
4ym3 | GALECTIN-4 (Homosapiens) | 6 / 7 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.19A | 6b8kA-4ym3A:22.4 | 6b8kA-4ym3A:24.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
5dux | GALECTIN-4 (Homosapiens) | 4 / 7 | ASN B 77TRP B 84GLU B 87ARG B 89 | LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A)LAT B 201 ( 3.7A) | 1.10A | 6b8kA-5duxB:24.6 | 6b8kA-5duxB:31.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
5dux | GALECTIN-4 (Homosapiens) | 6 / 7 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.21A | 6b8kA-5duxB:24.6 | 6b8kA-5duxB:31.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
5gzg | GALECTIN-8 (Homosapiens) | 6 / 7 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.17A | 6b8kA-5gzgA:23.1 | 6b8kA-5gzgA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 4 / 7 | ARG C 186ASN C 166GLU C 165ARG C 162 | LAT C 301 (-4.0A)NoneLAT C 301 ( 4.7A)LAT C 301 (-2.7A) | 1.16A | 6b8kA-6fofC:27.8 | 6b8kA-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B8K_A_W9TA300_0 (GALECTIN-3) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 7 / 7 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184ARG C 186 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.27A | 6b8kA-6fofC:27.8 | 6b8kA-6fofC:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B94_A_W9TA201_0 (GALECTIN-1) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 8 / 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.9A)LAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A)LAT A 999 ( 4.7A) | 0.33A | 6b94A-3m2mA:26.7 | 6b94A-3m2mA:92.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 6 / 8 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.55A | 6b94A-3wg1A:14.7 | 6b94A-3wg1A:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
4bmb | GALECTIN-8 (Homosapiens) | 6 / 8 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.42A | 6b94A-4bmbA:18.9 | 6b94A-4bmbA:29.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
4ym3 | GALECTIN-4 (Homosapiens) | 6 / 8 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.33A | 6b94A-4ym3A:18.7 | 6b94A-4ym3A:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
5dux | GALECTIN-4 (Homosapiens) | 6 / 8 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.31A | 6b94A-5duxB:19.5 | 6b94A-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
5dux | GALECTIN-4 (Homosapiens) | 5 / 8 | HIS B 63ASN B 77TRP B 84GLU B 87ARG B 89 | LAT B 201 (-3.9A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A)LAT B 201 ( 3.7A) | 1.11A | 6b94A-5duxB:19.5 | 6b94A-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
5gzg | GALECTIN-8 (Homosapiens) | 6 / 8 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.41A | 6b94A-5gzgA:18.7 | 6b94A-5gzgA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 4 / 8 | ARG C 186ASN C 166GLU C 165ARG C 162 | LAT C 301 (-4.0A)NoneLAT C 301 ( 4.7A)LAT C 301 (-2.7A) | 1.16A | 6b94A-6fofC:19.2 | 6b94A-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_A_W9TA201_0 (GALECTIN-1) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 7 / 8 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184ARG C 186 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.59A | 6b94A-6fofC:19.2 | 6b94A-6fofC:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6B94_B_W9TB201_0 (GALECTIN-1) |
3m2m | GALECTIN-1 (Rattusnorvegicus) | 9 / 10 | HIS A 44ASN A 46ARG A 48HIS A 52ASP A 54ASN A 61TRP A 68GLU A 71ARG A 73 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.9A)NoneLAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A)LAT A 999 ( 4.7A) | 0.38A | 6b94A-3m2mA:26.76b94B-3m2mA:25.9 | 6b94A-3m2mA:92.506b94B-3m2mA:92.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 6 / 10 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.62A | 6b94A-3wg1A:14.86b94B-3wg1A:14.2 | 6b94A-3wg1A:20.126b94B-3wg1A:20.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
4bmb | GALECTIN-8 (Homosapiens) | 6 / 10 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.41A | 6b94A-4bmbA:18.96b94B-4bmbA:18.6 | 6b94A-4bmbA:29.576b94B-4bmbA:29.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
4ym3 | GALECTIN-4 (Homosapiens) | 6 / 10 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.35A | 6b94A-4ym3A:18.76b94B-4ym3A:18.2 | 6b94A-4ym3A:24.466b94B-4ym3A:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
5dux | GALECTIN-4 (Homosapiens) | 6 / 10 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.33A | 6b94A-5duxB:19.46b94B-5duxB:19.1 | 6b94A-5duxB:27.696b94B-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
5gzg | GALECTIN-8 (Homosapiens) | 6 / 10 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.40A | 6b94A-5gzgA:18.76b94B-5gzgA:18.4 | 6b94A-5gzgA:23.176b94B-5gzgA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B94_B_W9TB201_0 (GALECTIN-1) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 7 / 10 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184ARG C 186 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.45A | 6b94A-6fofC:19.26b94B-6fofC:18.5 | 6b94A-6fofC:undetectable6b94B-6fofC:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FK2_A_SORA302_0 (GALECTIN-3) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 4 | ARG A 66GLU A 69GLU A 86ARG A 88 | LAT A 201 (-3.0A)NoneLAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.85A | 6fk2A-3wg1A:15.8 | 6fk2A-3wg1A:24.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FK2_A_SORA302_0 (GALECTIN-3) |
3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) | 4 / 4 | ARG A 88GLU A 86GLU A 69ARG A 66 | LAT A 201 (-4.4A)LAT A 201 (-2.8A)NoneLAT A 201 (-3.0A) | 0.97A | 6fk2A-3wg1A:15.8 | 6fk2A-3wg1A:24.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FK2_A_SORA302_0 (GALECTIN-3) |
6fof | GALECTIN-3,GALECTIN-3 (Homosapiens) | 4 / 4 | ARG C 162GLU C 165GLU C 184ARG C 186 | LAT C 301 (-2.7A)LAT C 301 ( 4.7A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.22A | 6fk2A-6fofC:27.9 | 6fk2A-6fofC:undetectable |